Researchers from the Cambridge Pancreatic Cancer Centre are part of a Stand Up To Cancer – Lustgarten Foundation Dream. The team involves collaborations with researchers in the USA with a focus on developing immunotherapy. Funding for this project is provided jointly by Stand Up 2 Cancer, The Lustgarten Foundation, The Fox Family Cancer Research Funding Trust and The American Association for Cancer Research. Professor Doug Fearon and Professor Duncan Jodrell will be leading the project in Cambridge, translating preclinical research using AMD3100 into a clinical trial. Read more about the Dream Team here and here.